Literature DB >> 12234233

New evidence for stroke prevention: scientific review.

Sharon E Straus1, Sumit R Majumdar, Finlay A McAlister.   

Abstract

CONTEXT: Stroke is a major cause of morbidity and mortality, and the application of evidence for stroke prevention varies considerably.
OBJECTIVE: To review the most recent, high-quality evidence for primary and secondary stroke prevention. DATA SOURCES AND STUDY SELECTION: Searches of MEDLINE, The Cochrane Library, and the ACP Journal Club were performed to identify English-language articles published from 1998 to 2001 that focused on primary and secondary stroke prevention. The references of each retrieved article were scanned, and experts in the field were contacted to identify additional relevant articles. DATA EXTRACTION: Each of the articles was appraised, and its quality was graded with levels of evidence based on specific scientific methods that affect a study's validity. DATA SYNTHESIS: For primary prevention of stroke, adequate blood pressure reduction, and treatment of hyperlipidemia, use of antithrombotic therapy in patients with atrial fibrillation and of antiplatelet therapy in patients with myocardial infarction are effective and supported by evidence from several randomized trials. Effective strategies for the secondary prevention of stroke include treatment of hypertension and hyperlipidemia, antithrombotic therapy for patients with atrial fibrillation, antiplatelet therapy, and carotid endarterectomy in patients with severe carotid artery stenosis.
CONCLUSIONS: Stroke is a major public health concern, and a significant body of evidence supports many primary and secondary prevention strategies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12234233     DOI: 10.1001/jama.288.11.1388

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  56 in total

1.  [Recommendations of the European Stroke Initiative (EUSI) for treatment of ischemic stroke--update 2003. Part 2: prevention and rehabilitation].

Authors:  Sonja Külkens; Peter Arthur Ringleb; Werner Hacke
Journal:  Nervenarzt       Date:  2004-04       Impact factor: 1.214

2.  Multifactorial approach to the primary and secondary prevention of atherosclerosis.

Authors:  Carl J Lavie; Richard V Milani
Journal:  Ochsner J       Date:  2003

Review 3.  Canadian Society of Transplantation: consensus guidelines on eligibility for kidney transplantation.

Authors:  Greg Knoll; Sandra Cockfield; Tom Blydt-Hansen; Dana Baran; Bryce Kiberd; David Landsberg; David Rush; Edward Cole
Journal:  CMAJ       Date:  2005-11-08       Impact factor: 8.262

4.  Shared mechanisms of ischaemic and haemorrhagic stroke: still a lot to learn.

Authors:  P Michel; J Bogousslavsky
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-01       Impact factor: 10.154

Review 5.  Primary and secondary prevention of stroke by antihypertensive treatment in clinical trials.

Authors:  Guido Grassi; Francesca Arenare; Fosca Quarti Trevano; Raffaella Dell'Oro; And Giuseppe Mancia
Journal:  Curr Hypertens Rep       Date:  2007-08       Impact factor: 5.369

6.  The Cerebrovascular Attitudes and Beliefs Scale (CABS-R): the factor structure and psychometric properties of a tool for assessing stroke-related health beliefs.

Authors:  Karen A Sullivan; Katherine M White; Ross McD Young; Clinton Scott
Journal:  Int J Behav Med       Date:  2010-03

7.  [European Stroke Organisation 2008 guidelines for managing acute cerebral infarction or transient ischemic attack : part 2].

Authors:  P D Schellinger; P Ringleb; W Hacke
Journal:  Nervenarzt       Date:  2008-10       Impact factor: 1.214

8.  Competing cardiovascular outcomes associated with subclinical atherosclerosis (from the Multi-Ethnic Study of Atherosclerosis).

Authors:  Chintan S Desai; Hongyan Ning; Joseph Kang; Aaron R Folsom; Joseph F Polak; Christopher T Sibley; Russell Tracy; Donald M Lloyd-Jones
Journal:  Am J Cardiol       Date:  2013-03-15       Impact factor: 2.778

Review 9.  Choosing the ideal drug for hypertension after ischemic stroke.

Authors:  Eduard Rozner; Arnold Eggers; Daniel Rosenbaum
Journal:  Curr Hypertens Rep       Date:  2009-08       Impact factor: 5.369

Review 10.  Antihypertensive treatment and stroke prevention: from recent meta-analyses to the PRoFESS trial.

Authors:  Guido Grassi; Fosca Quarti-Trevano; Raffaella Dell'oro; Giuseppe Mancia
Journal:  Curr Hypertens Rep       Date:  2009-08       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.